KalVista Pharmaceuticals Statistics Share Statistics KalVista Pharmaceuticals has 49.95M
shares outstanding. The number of shares has increased by 15.04%
in one year.
Shares Outstanding 49.95M Shares Change (YoY) 15.04% Shares Change (QoQ) 0% Owned by Institutions (%) 99.99% Shares Floating 38.59M Failed to Deliver (FTD) Shares 48,093 FTD / Avg. Volume 4.05%
Short Selling Information The latest short interest is 9.25M, so 18.61% of the outstanding
shares have been sold short.
Short Interest 9.25M Short % of Shares Out 18.61% Short % of Float 21.01% Short Ratio (days to cover) 3.52
Valuation Ratios The PE ratio is -3.73 and the forward
PE ratio is -3.69.
KalVista Pharmaceuticals's PEG ratio is
-0.51.
PE Ratio -3.73 Forward PE -3.69 PS Ratio 0 Forward PS 18 PB Ratio 7.17 P/FCF Ratio -4.47 PEG Ratio -0.51
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for KalVista Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.35,
with a Debt / Equity ratio of 0.07.
Current Ratio 5.35 Quick Ratio 5.35 Debt / Equity 0.07 Debt / EBITDA -0.04 Debt / FCF -0.04 Interest Coverage -32.5
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.22M Employee Count 150 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 3.39M Effective Tax Rate -1.88%
Stock Price Statistics The stock price has increased by -3.47% in the
last 52 weeks. The beta is 0.04, so KalVista Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.04 52-Week Price Change -3.47% 50-Day Moving Average 13.55 200-Day Moving Average 11.34 Relative Strength Index (RSI) 36.11 Average Volume (20 Days) 1,188,001
Income Statement
Revenue n/a Gross Profit n/a Operating Income -188M Net Income -183.44M EBITDA -173.33M EBIT -174.27M Earnings Per Share (EPS) -3.69
Full Income Statement Balance Sheet The company has 98.64M in cash and 6.31M in
debt, giving a net cash position of 92.34M.
Cash & Cash Equivalents 98.64M Total Debt 6.31M Net Cash 92.34M Retained Earnings -653.17M Total Assets 250.77M Working Capital 196.52M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -152.91M
and capital expenditures 0, giving a free cash flow of -152.91M.
Operating Cash Flow -152.91M Capital Expenditures n/a Free Cash Flow -152.91M FCF Per Share -3.08
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields KALV does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for KALV is $27,
which is 115.7% higher than the current price. The consensus rating is "Buy".
Price Target $27 Price Target Difference 115.7% Analyst Consensus Buy Analyst Count 9
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 22, 2016. It was a
backward
split with a ratio of 1:14.
Last Split Date Nov 22, 2016 Split Type backward Split Ratio 1:14
Scores Altman Z-Score -2.58 Piotroski F-Score 1
